Evidence map›Paper›PMID 27818279›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2017

Comparative genomics of Tunisian Leishmania major isolates causing human cutaneous leishmaniasis with contrasting clinical severity.

Amel Ghouila, Fatma Z Guerfali, Chiraz Atri, Aymen Bali, Hanene Attia, Rabiaa M Sghaier, Ghada Mkannez, Nicholas J Dickens, Dhafer Laouini

Abstract readComparative Study
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Assessment of Incubation Period of Cutaneous Leishmaniasis due toThe American journal of tropical medicine and hygiene · 2020
    Article
  3. Article
  4. Genomic Diversification, Structural Plasticity, and Hybridization inFrontiers in cellular and infection microbiology · 2020
    Article
  5. Genes · 2019
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amel GhouilaInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia.
Fatma Z GuerfaliInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia. Electronic address: fatma.guerfali@gmail.com.
Chiraz AtriInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia.
Aymen BaliInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia.
Hanene AttiaInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia.
Rabiaa M SghaierInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia.
Ghada MkannezInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia.
Nicholas J DickensWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Sir Graeme Davies Building, 120 University Place, Glasgow G12 8TA, UK.
Dhafer LaouiniInstitut Pasteur de Tunis, LR11IPT02, Laboratory of Transmission, Control and Immunobiology of Infections (LTCII), Tunis, Belvédère, 1002, Tunisia; Université Tunis El Manar, Tunis 1068, Tunisia.

Funding

L. major infection: Natural history and determinants of resistanceP50AI074178 · NIAID · INSTITUT PASTEUR DE TUNIS · PI BEN SALAH, AFIF · 2007 to 2011
$2.4M
NIAID NIH HHS P50 AI074178Wellcome TrustWellcome Trust 104111
6 · The paper itself

Abstract

Zoonotic cutaneous leishmaniasis caused by Leishmania (L.) major parasites affects urban and suburban areas in the center and south of Tunisia where the disease is endemo-epidemic. Several cases were reported in human patients for which infection due to L. major induced lesions with a broad range of severity. However, very little is known about the mechanisms underlying this diversity. Our hypothesis is that parasite genomic variability could, in addition to the host immunological background, contribute to the intra-species clinical variability observed in patients and explain the lesion size differences observed in the experimental model. Based on several epidemiological, in vivo and in vitro experiments, we focused on two clinical isolates showing contrasted severity in patients and BALB/c experimental mice model. We used DNA-seq as a high-throughput technology to facilitate the identification of genetic variants with discriminating potential between both isolates. Our results demonstrate that various levels of heterogeneity could be found between both L. major isolates in terms of chromosome or gene copy number variation (CNV), and that the intra-species divergence could surprisingly be related to single nucleotide polymorphisms (SNPs) and Insertion/Deletion (InDels) events. Interestingly, we particularly focused here on genes affected by both types of variants and correlated them with the observed gene CNV. Whether these differences are sufficient to explain the severity in patients is obviously still open to debate, but we do believe that additional layers of -omic information is needed to complement the genomic screen in order to draw a more complete map of severity determinants.

Indexed as

Endemic DiseasesGene DosagePhylogenyAnimalsChromosomesDNA, ProtozoanFemaleFollow-Up StudiesGenomicsHumansINDEL MutationLeishmania majorLeishmaniasis, CutaneousMiceMice, Inbred BALB CPhylogeographyDNA, ProtozoanClinical isolatesGenomic variabilityHigh-throughput genomic screeningLeishmania majorSeverityZoonotic cutaneous leishmaniasis

Identifiers

PMID27818279
PMCPMC5376240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.